We think all investors should try to buy and hold high quality multi-year winners. And highest quality companies can see their share prices grow by huge amounts. Don't believe it? Then look at the ...

With its stock down 38% over the past three months, it is easy to disregard Compumedics (ASX:CMP). It is possible that the markets have ignored the company's differing financials and decided to ...

MELBOURNE, Australia--(BUSINESS WIRE)--Compumedics Limited (ASX: CMP), a world leading supplier of innovative medical technology for patient monitoring, has in collaboration with Beijing Fistar and ...

Compumedics has received FDA approval to market Falcon, its second home sleep testing solution in the US, with potential to substantially boost its revenue. Falcon to complement Compumedics Somfit ...

Compumedics secures two lucrative sales for its Somfit sleep device with combined revenues approaching $2 million Sales to a leading CRO in US and a Finnish pharmaceutical company support strategy to ...

Compumedics delivers breakout performance in FY25 with record revenue and sales orders, a return to profitability, and accelerating growth in the US and SaaS segments. Compumedics (ASX:CMP) said the ...

China Brain Project rolls out neuro-AI push Compumedics dual-helmet MEG lights up Tianjin labs ASX health stocks surge deeper into China A few years back, China kicked off what might be one of the ...

Compumedics Limited (AU:CMP) has released an update. Compumedics Limited projects a record-breaking year with over $50 million in sales orders and at least $46 million in revenue for FY24, driven by ...

Compumedics (ASX:CMP) said the last financial year laid a stronger more scalable business model for FY26 and beyond with record sales orders of $63.4 million, up 22% on FY24. EBITDA increased to ~$3m, ...